If there was ever a time for an informed discussion about the purpose and use of Risk Evaluation and Mitigation Strategies (REMS), it is now. Rather than impeding the arrival of more effective treatments to the market, Congress gave the Food and Drug
Read More...
Read the complete post at http://healthaffairs.org/blog/2015/05/14/in-ensuring-timely-approval-of-generic-drugs-safety-must-come-first/
Posted
May 14 2015, 07:37 AM
by
Health Affairs Blog